Related Experiment Video
Updated: Jul 10, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Pandemic flu vaccine: are we doing enough?
1University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, Maryland, USA. Jcampbel@medicine.umaryland.edu
Abstract:
Influenza experts have been trying for a long time to convince other scientists, the public health community, and the general population that preparations for a pandemic should be a priority. But it was not until the highly pathogenic H5N1 avian strain emerged, causing a great epizootic and infecting and killing people exposed to infected birds, that research on this topic exploded. Below I discuss some truly phenomenal advances that have emerged from this newfound interest in pandemic influenza, to show that, yes, we are doing enough.
Related Concept Videos
Vaccinations
Influenza
Smallpox
Vaccines
Infectious Diseases and Their Occurrence
Vaccine Production
